Illumina, Inc.
- ILMN
- NASDAQ
- Medical - Diagnostics & Research
- DNA Sequencing (NGS)
- Microarray Technology
$262.54
Today −2.01%Quote Oct 16, 2026, 08:00 PM UTC
+7.08%over the last month
Max drawdown −10.6%From 1-month high −10.6%3 months +42.2%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$39.64B
Quote Oct 16
Next earnings
Oct 29
Expected, not confirmed
Analyst target
$241.00
−8.2% from here
Floor
$251.66
4.1% below price
Where the price sits
50 analysts
Analyst range, low to high
$155.00$305.00
- Price $262.54
- Resistance $280.51
- Consensus $241.00
Analysts' average target sits about 8% lower. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about ILMNPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
Q2 2026 revenue $1.16B
- Sequencing$1.05B90.9%
- Microarray$105.0M9.1%
Industry
Medical - Diagnostics & Research
Employees
8,600